SCHEMBL17500064

SCHEMBL17500064

O=C(OCc1ccn([C@H]2C[C@@H](Nc3cc(-c4ccccc4)on3)C2)n1)c1cc(-c2ccccc2)on1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 3/20 0.43
▸ RAB9A P51151 5/20 0.41
▸ NPC1 O15118 4/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ S1PR1 P21453 1/20 0.41
▸ FAAH O00519 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ GAA P10253 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ SCD O00767 4/20 0.39
▸ SCD5 Q86SK9 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17500065 1.00 HIF1A (0.43) HIF1ARAB9ANPC1CYP1A2CYP2D6
SCHEMBL17374348 0.90 NPC1 (0.53) HIF1ARAB9ANPC1S1PR1FAAH
SCHEMBL17374350 0.90 NPC1 (0.53) HIF1ARAB9ANPC1S1PR1FAAH
SCHEMBL17374178 0.77 RAB9A (0.58) HIF1ARAB9ANPC1S1PR1FAAH
SCHEMBL17374175 0.77 RAB9A (0.58) HIF1ARAB9ANPC1S1PR1FAAH
SCHEMBL17374476 0.77 RAB9A (0.58) HIF1ARAB9ANPC1S1PR1FAAH
SCHEMBL20200053 0.76 RAB9A (0.56) HIF1ARAB9ANPC1S1PR1FAAH
SCHEMBL18584501 0.72 NPC1 (0.51) HIF1ARAB9ANPC1S1PR1FAAH
SCHEMBL17381661 0.69 NPC1 (0.50) HIF1ARAB9ANPC1S1PR1FAAH
SCHEMBL17381663 0.69 NPC1 (0.50) HIF1ARAB9ANPC1S1PR1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015196071-A9 COMPOUNDS, COMPOSITIONS AND METHODS OF INCREASING CFTR ACTIVITY PROTEOSTASIS THERAPEUTICS, INC. (US) 2016-02-18 — — WO disclosed
Send feedback